Search research articles
Contact Us
Filters
Showing results (21-30 of 191) with videos related to
Page
of 20
Sort By:
Hematology/Oncology Clinics of North America
|
August 11, 1992
Oncogenes in ovarian cancer
A Berchuck, M F Kohler, R C Bast
Clinical Obstetrics and Gynecology
|
March 11, 1992
The use of tumor markers in the management of patients with gynecologic carcinomas
A Berchuck, M P Boente, R C Bast
Cancer
|
August 15, 1991
Adjuvant intraperitoneal chromic phosphate therapy for women with apparent early ovarian carcinoma who have not undergone comprehensive surgical staging
J T Soper, A Berchuck, D L Clarke-Pearson
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
June 29, 2006
Use of trastuzumab in the treatment of metastatic endometrial cancer
E Jewell, A A Secord, T Brotherton, et al.
Obstetrics and Gynecology
|
January 1, 1991
The clinical significance of blood transfusion at the time of radical hysterectomy
J T Soper, A Berchuck, D L Clarke-Pearson
Anticancer Research
|
January 1, 1989
Effect of epidermal growth factor on ornithine decarboxylase activity in A431 cells
R Yazigi, A Berchuck, M L Casey, et al.
Nature Genetics
|
May 1, 1994
Mutations of the E-cadherin gene in human gynecologic cancers
J I Risinger, A Berchuck, M F Kohler, et al.
Prostaglandins
|
October 1, 1989
Transforming growth factor-beta inhibits prostaglandin production in amnion and A431 cells
A Berchuck, P C MacDonald, L Milewich, et al.
Molecular and Cellular Endocrinology
|
May 1, 1988
Epidermal growth factor, vanadate, and 12-O-tetradecanoylphorbol-13-acetate inhibit growth and stimulate prostaglandin E2 production in A431 cells
A Berchuck, P C MacDonald, L Milewich, et al.
Gynecologic Oncology
|
June 1, 1991
The role of partial sigmoid colectomy for debulking epithelial ovarian carcinoma
J T Soper, G Couchman, A Berchuck, et al.
Page
of 20
Search research articles
Search
Showing results (21-30 of 191) with videos related to
Sort By:
Page
of 20
Hematology/Oncology Clinics of North America
|
August 11, 1992
Oncogenes in ovarian cancer
A Berchuck, M F Kohler, R C Bast
Clinical Obstetrics and Gynecology
|
March 11, 1992
The use of tumor markers in the management of patients with gynecologic carcinomas
A Berchuck, M P Boente, R C Bast
Cancer
|
August 15, 1991
Adjuvant intraperitoneal chromic phosphate therapy for women with apparent early ovarian carcinoma who have not undergone comprehensive surgical staging
J T Soper, A Berchuck, D L Clarke-Pearson
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
June 29, 2006
Use of trastuzumab in the treatment of metastatic endometrial cancer
E Jewell, A A Secord, T Brotherton, et al.
Obstetrics and Gynecology
|
January 1, 1991
The clinical significance of blood transfusion at the time of radical hysterectomy
J T Soper, A Berchuck, D L Clarke-Pearson
Anticancer Research
|
January 1, 1989
Effect of epidermal growth factor on ornithine decarboxylase activity in A431 cells
R Yazigi, A Berchuck, M L Casey, et al.
Nature Genetics
|
May 1, 1994
Mutations of the E-cadherin gene in human gynecologic cancers
J I Risinger, A Berchuck, M F Kohler, et al.
Prostaglandins
|
October 1, 1989
Transforming growth factor-beta inhibits prostaglandin production in amnion and A431 cells
A Berchuck, P C MacDonald, L Milewich, et al.
Molecular and Cellular Endocrinology
|
May 1, 1988
Epidermal growth factor, vanadate, and 12-O-tetradecanoylphorbol-13-acetate inhibit growth and stimulate prostaglandin E2 production in A431 cells
A Berchuck, P C MacDonald, L Milewich, et al.
Gynecologic Oncology
|
June 1, 1991
The role of partial sigmoid colectomy for debulking epithelial ovarian carcinoma
J T Soper, G Couchman, A Berchuck, et al.
Page
of 20